LIVN News and Press, LivaNova PLC From 02/22/23

The following slide deck was published by LivaNova PLC in conjunction with their 2022 Q4 earnings call. For further details see: LivaNova PLC 2022 Q4 - Results - Earnings Call Presentation

LivaNova PLC press release ( NASDAQ: LIVN ): Q4 Non-GAAP EPS of $0.81 beats by $0.08 . Revenue of $274.9M (+1.8% Y/Y) beats by $12.74M . LivaNova expects revenue for full-year 2023 to grow between 3 and 5 percent on a constant-currency basis. Foreign currency is expe...

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today reported results for the quarter and full year ended December 31, 2022 and issued guidance for 2023. Fourth-Quarter Financial Summary and Highlights 1 Fourth-quarter revenue of...

Summary LivaNova provides high-tech medical devices for the benefit of healthcare professionals, patients, and healthcare systems around the world. Considering the geographic diversification of the business model, LivaNova’s revenue model appears to be more solid than that of com...

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced the start of a limited commercial release for the Essenz™ Perfusion System*. The release has been initiated in select centers throughout Europe, following a successful clinical experien...

New device expands access to the latest technology for legacy VNS Therapy patients with drug-resistant epilepsy in the U.S. LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today launched SenTiva DUO™, an implantable pulse generator (IP...

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its fourth-quarter and full-year 2022 results on Wednesday, February 22, 2023 at 1 p.m. London time (8 a.m. Eastern Time). The Company will release its fourth-quarter an...

Summary David Einhorn's 13F stock portfolio value increased from $1.29B to $1.41B this quarter. Greenlight increased Kyndryl Holdings, LivaNova PLC, and Southwestern Energy while dropping Chemours, International Seaways, and Warner Bros. Discovery. The largest three positions are at...

Summary INMD provides a prime opportunity for investors to benefit from the growing demand for non-surgical cosmetic procedures that rely on energy-based devices. INMD manufactures and sells energy based devices used by physicians in these procedures and has between 2019 and 2022 seen a...

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced its participation in the American Epilepsy Society (AES) 2022 Annual Meeting, taking place December 2-6 in Nashville, Tennessee. The Company’s therapies and technologies will be feature...